... a big step in the battle against heart disease - and the approval is a triumph for Regeneron Pharmaceuticals, the Tarrytown, N.Y.-based biotechnology company that invented it. Praluent is likely to be more widely used, and to cost more, than Wall ...
http://ift.tt/1Is1qw6
No comments:
Post a Comment